Cargando…

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

INTRODUCTION: Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease with a heterogeneous course and varying degrees of severity and organ damage; thus, there is increasing interest in identifying biomarkers for SLE. In this study we correlated the combined expression level of multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Qiong, Chen, Xiaoqing, Cui, Huijuan, Guo, Yanzhi, Chen, Jing, Shen, Nan, Bao, Chunde
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592795/ https://www.ncbi.nlm.nih.gov/pubmed/18793417 http://dx.doi.org/10.1186/ar2510

Ejemplares similares

Multidimensional Single Cell Based STAT Phosphorylation Profiling Identifies a Novel Biosignature for Evaluation of Systemic Lupus Erythematosus Activity
por: Huang, Xinfang, et al.
Publicado: (2011)

Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus
por: Bauer, Jason W, et al.
Publicado: (2006)

Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells
por: Huang, Xiangyang, et al.
Publicado: (2008)

Interferon-induced versus chemokine transcripts as lupus biomarkers
por: Crow, Mary K, et al.
Publicado: (2008)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2018)

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Cytokines and Chemokines in Neuropsychiatric Syndromes of Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2010)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
por: Harden, Olivia C., et al.
Publicado: (2020)

Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus
por: Ntasis, Vasilis F., et al.
Publicado: (2020)

Evaluation of Thrombocytopenia in Systemic Lupus Erythematosus and Correlation with Different Organs Damages
por: Ktona, Ergeta, et al.
Publicado: (2014)

Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage
por: BARBULESCU, A., et al.
Publicado: (2015)

Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus
por: Wu, Yanfang, et al.
Publicado: (2015)

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003)

Systemic lupus erythematosus and the type I interferon system
por: Rönnblom, Lars, et al.
Publicado: (2003)

Pregnancy outcomes among Chinese women with and without systemic lupus erythematosus: a retrospective cohort study
por: Wu, Jiayue, et al.
Publicado: (2018)

Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism
por: Ni, Jiajia, et al.
Publicado: (2022)

Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study
por: Wu, Jiayue, et al.
Publicado: (2019)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
por: Cham, Candace M., et al.
Publicado: (2012)

Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus
por: Wu, Guo-Cui, et al.
Publicado: (2016)

Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus
por: Dominguez-Gutierrez, Paul R, et al.
Publicado: (2014)

Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay
por: Petrackova, Anna, et al.
Publicado: (2017)

Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2012)

Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2013)

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus
por: Raymond, Warren, et al.
Publicado: (2018)

The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus
por: Qiu, Wenlin, et al.
Publicado: (2022)

Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity
por: Wu, Qian, et al.
Publicado: (2011)

Development of a Conceptual Model to Understand Disease Burden in Patients With Systemic Lupus Erythematosus and Organ Damage
por: Broderick, Lynne, et al.
Publicado: (2023)

Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile
Publicado: (1989)

The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus
por: Harley, Isaac T. W., et al.
Publicado: (2010)

Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus
por: Zeng, Yanli, et al.
Publicado: (2021)

Increased Macroautophagy in Interferon-Gamma-Producing T Cells from Patients with Newly Diagnosed Systemic Lupus Erythematosus
por: Luo, Xiong-Yan, et al.
Publicado: (2018)

Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus
por: Huang, Saisai, et al.
Publicado: (2023)

Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
por: Bengtsson, Anders A, et al.
Publicado: (2014)

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States
por: Bell, Christopher F, et al.
Publicado: (2022)

The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus
por: Fan, Wei, et al.
Publicado: (2023)

Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort
por: Al Sawah, Sarah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6gcmhn8lebbif672d61n25anca